Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Fidia Spa ( (IT:FDA) ) is now available.
Fidia S.p.A. has converted four bonds from the seventh tranche of its convertible bond loan reserved for Global Growth Holding Limited into 10,000,000 new shares at a price of €0.004 per share. The new shares are admitted directly to trading on the regulated market under the existing prospectus, marking another step in the company’s ongoing capital-strengthening programme.
Following this conversion, the POC has been subscribed for a total nominal amount of €1.75 million, fully matched by the related capital increase, with no outstanding bonds remaining in the seventh tranche. As a result, Fidia’s share capital rises by €40,000 to €11,597,761.90 and its total shares increase to 166,078,639, further diluting existing shareholders while bolstering the company’s equity base and financial flexibility.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in numerical control technology and high-performance integrated milling systems, serving mainly the automotive mould and aerospace sectors. With more than 50 years of experience and about 135 employees, the group offers end-to-end milling solutions, including numerical controls, high-speed milling machines and CAM software for complex shapes.
Average Trading Volume: 3,552,320
Technical Sentiment Signal: Strong Sell
Current Market Cap: €568.7K
Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.